Seelos therapeutics to sponsor and participate in wonderland, the world's leading psychedelic event

-seelos' sls-002 (intranasal racemic ketamine) is believed to be the only drug in the psychedelic class currently being developed specifically to treat the symptoms of suicidality associated with major depression. -seelos senior management will sponsor the press breakfast on friday november 4 th at 8:30am and take part in 2 panel discussions on saturday november 5 th.
SEEL Ratings Summary
SEEL Quant Ranking